[反感性寡核酸作为神经遗传障碍的新疗法]
1University of Hong Kong Shenzhen Hospital, Shenzhen, Guangdong 518053, China. fanliyuansophere@126.com.
概括
反感性寡核酸 (ASOs) 正在成为神经系统疾病的强大治疗方法. 本综述详细介绍了ASO机制,已批准的药物及其在精准医学中的作用,指导遗传咨询师.
科学领域:
- 生物技术是生物技术.
- 遗传学 遗传学 是一个
- 药理学 药理学是指药理学的学科.
背景情况:
- 反感性寡核酸 (ASOs) 从研究工具演变为神经系统疾病的批准治疗方法.
- 几种ASO药物,包括eteplirsen和nusinersen,已获得FDA批准,突出了它们的治疗潜力.
- 精准医学的兴起意味着针对性治疗策略的新时代.
研究的目的:
- 详细阐述ASO疗法的作用机制,修改,副作用和输送途径.
- 系统地审查FDA批准的ASO疗法及其在神经疾病中的应用.
- 讨论有关ASO疗法的遗传咨询师面临的挑战和考虑.
主要方法:
- 关于ASO机制和应用的文献综述.
- 美国食品和药物管理局批准的ASO疗法的系统摘要.
- 对ASO治疗实施的挑战和未来考虑的分析.
主要成果:
- ASO疗法为治疗神经系统疾病提供了一种新的方法,其有效性已被证明.
- 多种ASO疗法已获得批准,更多的在临床试验中.
- 精确的基因诊断对于成功治疗ASO至关重要.
结论:
- ASO疗法代表了神经疾病精密医学的重大进步.
- 了解ASO机制,应用和限制对于医疗保健专业人员和遗传咨询师来说至关重要.
- 遗传咨询师在患者教育和ASO疗法的治疗途径指导中发挥着关键作用.
相关概念视频
siRNA - Small Interfering RNAs
16.6K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.6K
Experimental RNAi
6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
RNA Interference
25.9K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
25.9K
CRISPR
49.3K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
49.3K


